SCHEMBL17425447

SCHEMBL17425447

CC1(C)c2ccccc2-c2ccc(-c3nc(-c4ccccc4)nc(-c4cc(-c5ccccc5)cc(-c5cccc6c5oc5c(-c7ccc(-c8ccccc8)cc7)cccc56)c4)n3)cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 8/20 0.33
PDK2 Q15119 3/20 0.33
PIK3CD O00329 3/20 0.32
PIK3CA P42336 3/20 0.32
PIK3CB P42338 3/20 0.32
PIK3CG P48736 3/20 0.32
ALOX5 P09917 1/20 0.32
ALDH1A1 P00352 4/20 0.32
MAPT P10636 3/20 0.32
HPGD P15428 3/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
KDM4E B2RXH2 3/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
TP53 P04637 2/20 0.31
TSHR P16473 2/20 0.31
NFKB1 P19838 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MAPK1 P28482 1/20 0.31
NFKB2 Q00653 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17425736 1.00 PRKDC (0.33) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL19271502 0.97 ALOX5 (0.34) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL17640299 0.97 ALOX5 (0.34) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL17425709 0.96 ALOX5 (0.35) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL17640309 0.95 PDK2 (0.36) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL17425485 0.95 ALOX5 (0.36) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL17425667 0.95 PDK2 (0.34) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL17640302 0.95 ALOX5 (0.36) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL17425536 0.95 PDK2 (0.34) PRKDCPDK2PIK3CDPIK3CAPIK3CB
SCHEMBL17425483 0.94 PRKDC (0.36) PRKDCPDK2PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170054087-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-02-23 US disclosed
US-20160093808-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-03-31 US disclosed
US-20160028021-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-28 US disclosed
EP-2966706-A2 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2016-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160028021-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OR10J3 PRKDC 4297/4885PDK2 1226/4885PIK3CD 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.